These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16447721)

  • 21. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease.
    Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Haploidentical 2- or 3-antigen-mismatched hematopoietic stem cell transplantation using in vivo Campath-1H].
    Kanda Y
    Rinsho Ketsueki; 2006 Jul; 47(7):607-17. PubMed ID: 16910570
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 29. [Present status in hematopoietic stem cell transplantation: bone marrow bank and non-relative bone marrow transplantation].
    Kodera Y
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1274-80. PubMed ID: 16097579
    [No Abstract]   [Full Text] [Related]  

  • 30. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematologic malignancies in children.
    Huang X; Liu D; Liu K; Xu L; Chen H; Han W; Chen Y; Wang Y; Zhang X
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):91-4. PubMed ID: 19147085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
    Ottinger HD; Müller CR; Goldmann SF; Albert E; Arnold R; Beelen DW; Blasczyk R; Bunjes D; Casper J; Ebell W; Ehninger G; Eiermann T; Einsele H; Fauser A; Ferencik S; Finke J; Hertenstein B; Heyll A; Klingebiel T; Knipper A; Kremens B; Kolb HJ; Kolbe K; Lenartz E; Lindemann M; Müller CA; Mytilineos J; Niederwieser D; Runde V; Sayer H; Schaefer UW; Schmitz N; Schröder S; Schulze-Rath R; Schwerdtfeger R; Siegert W; Thiele B; Zander AR; Grosse-Wilde H
    Ann Hematol; 2001 Dec; 80(12):706-14. PubMed ID: 11797110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
    Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint MT
    Haematologica; 1999 Jun; 84 Suppl EHA-4():50-2. PubMed ID: 10907467
    [No Abstract]   [Full Text] [Related]  

  • 33. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent progress in hematopoietic stem cell transplantation].
    Shinagawa K
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):727-35. PubMed ID: 16770089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
    Remes K; Luoma S; Salmi TT; Tarja-Terttu P; Itälä M; Kauppila M; Nikoskelainen J; Putkonen M; Kairisto V; Rajamäki A; Tienhaara A; Pyrhönen S; Rauhala A
    Duodecim; 2005; 121(19):2085-97. PubMed ID: 16300297
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
    Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.